Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Ganaxolone for Children With Autism Spectrum Disorder

NCT07635862 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07635862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07635862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Ganaxolone for Children With Autism Spectrum Disorder
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
January 1, 2030
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism in children, autism spectrum disorder, autistic disorder in children and adolescents